Gainers:
Solutia Inc. (SOA) is jumping 42 percent to $27.75 based on the news that Eastman Chemical Co. (EMN) has agreed to acquire the company for $27.65 per share or about $4.7 billion, including the assumption of debt.
Transocean Inc. (RIG) is up over 6 percent to $50.30 based on the news that a federal judge has ruled that BP (BP) is required to indemnify the owner of drilling rig against compensatory damages from the 2010 Gulf of Mexico oil spill.
Altria Group, Inc. (MO) is rising over 1 percent to $29.09. The company's fourth quarter profit declined 9 percent from the previous year period. Net revenues rose 3.4 percent. Altria also announced that its Chairman and Chief Executive Officer, Michael Szymanczyk, has decided to retire from the company.
Cepheid (CPHD) is surging 23 percent to $42.20. The company's fourth quarter non-GAAP net income increased from the year-ago quarter. The company slipped to a loss on a GAAP basis, reflecting a one-time, non-cash charge associated with the termination of a patent license.
Decliners:
Honeywell International Inc. (HON) is falling more than 2 percent to $56.51.. The company slipped to a loss in its fourth quarter. Sales were up 8 percent. Proforma earnings per share were above Wall Street view.
Ford Motor Co. (F) is down 5 percent to $12.17. The company's profit jumped from the year-ago quarter, including a favorable one-time, non-cash special item. Fourth quarter pre-tax operating profit declined from the prior year quarter. The company said it is well on track to achieve the goals in its mid-decade outlook.
Starbucks Corp. (SBUX) is down nearly 2 percent to $47.52. The company's first quarter earnings improved 10 percent from the year-ago quarter. Total net revenues rose 16 percent. Both earnings per share and revenues were above Wall Street view. The company raised the lower end of its 2012 earnings forecast, although the guidance range was below the consensus estimate.
Chevron Corp. (CVX) is down over 1 percent to $104.99 as the company's fourth quarter profit declined from the prior year period. Sales and other operating revenues increased from the year-ago quarter.
Infinity Pharmaceuticals, Inc. (INFI) is plunging 45 percent to $5.49 as the company voluntarily stopped the Phase 2 study of Saridegib Plus Gemcitabine in patients with metastatic pancreatic cancer as preliminary analysis showed trial would not meet primary endpoint of overall survival.
Riverbed Technology, Inc. (RVBD) is declining 14 percent to $25.75. The company's fourth quarter profit and revenue improved from the previous year period. Both non-GAAP earnings per share and revenue were above consensus. The company has guided first quarter non-GAAP earnings per share and revenue below consensus.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.